ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
118.532,68
-1,33%
S&P 500
5.942,47
1,26%
US Dollar vs BRL
6,1822
0,00%
Bitcoin
98.311,97
0,11%
Brent Oil
76,495
0,00%
As Melhores Corretoras Online
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NYSE
  6. Nevro Corp (NVRO)

  7. Nevro Corp (NVRO) Notícias

NVRO

Nevro (NVRO)

Nevro Corp
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NYSE:NVRO
DataHoraFonteTítuloCódigoCompanhia
02/01/202518:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVRONevro Corp
17/12/202418:30PR Newswire (US)Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08NYSE:NVRONevro Corp
04/12/202418:27Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNYSE:NVRONevro Corp
18/11/202410:30PR Newswire (US)New Study Demonstrates Multiple Advantages of Nevro1™, the Novel SI Joint Fusion System by Nevro, in Comparison to Posterolateral and Lateral ApproachesNYSE:NVRONevro Corp
14/11/202419:31Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NYSE:NVRONevro Corp
14/11/202419:18Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NYSE:NVRONevro Corp
14/11/202418:11Edgar (US Regulatory)Form 8-K - Current reportNYSE:NVRONevro Corp
12/11/202409:00PR Newswire (US)Nevro's HFX iQ™ Spinal Cord Stimulation with AI Technology Receives CE Mark Certification in Europe, Increasing Product Expansion GloballyNYSE:NVRONevro Corp
11/11/202418:05PR Newswire (US)Nevro Reports Third-Quarter 2024 Financial ResultsNYSE:NVRONevro Corp
29/10/202417:30PR Newswire (US)New Data Demonstrates Long-Term Improvements in Pain Intensity with Nevro's High-Frequency Spinal Cord Stimulation TherapyNYSE:NVRONevro Corp
10/10/202417:45PR Newswire (US)Nevro to Report Third-Quarter 2024 Financial Results and Host Earnings Conference Call on November 11, 2024NYSE:NVRONevro Corp
24/09/202409:00PR Newswire (US)Nevro Announces the Launch of HFX AdaptivAI™, the Only AI-Driven Technology in Spinal Cord StimulationNYSE:NVRONevro Corp
28/08/202417:15PR Newswire (US)Nevro to Present at Wells Fargo 2024 Healthcare ConferenceNYSE:NVRONevro Corp
06/08/202417:48Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:NVRONevro Corp
06/08/202417:12Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:NVRONevro Corp
06/08/202417:05PR Newswire (US)Nevro Reports Second-Quarter 2024 Financial ResultsNYSE:NVRONevro Corp
09/07/202417:15PR Newswire (US)Nevro to Report Second-Quarter 2024 Financial Results and Host Earnings Conference Call on August 6, 2024NYSE:NVRONevro Corp
11/06/202417:15PR Newswire (US)Nevro to Present at Truist Securities MedTech ConferenceNYSE:NVRONevro Corp
17/05/202417:40Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:NVRONevro Corp
09/05/202417:05PR Newswire (US)Nevro to Present at BofA Securities 2024 Healthcare ConferenceNYSE:NVRONevro Corp
07/05/202417:05PR Newswire (US)Nevro Reports First-Quarter 2024 Financial ResultsNYSE:NVRONevro Corp
17/04/202409:30PR Newswire (US)Nevro to Report First-Quarter 2024 Financial Results and Host Earnings Conference Call on May 7, 2024NYSE:NVRONevro Corp
28/02/202418:10PR Newswire (US)Nevro Receives FDA 510(k) Clearance to Use SI Fixation System Without Need to Include Lateral ScrewNYSE:NVRONevro Corp
21/02/202418:06PR Newswire (US)Nevro Enters Into Cooperation Agreement With Engaged CapitalNYSE:NVRONevro Corp
21/02/202418:05PR Newswire (US)Nevro Reports Fourth-Quarter and Full-Year 2023 Financial ResultsNYSE:NVRONevro Corp
14/02/202417:47Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNYSE:NVRONevro Corp
01/02/202418:30PR Newswire (US)Nevro Announces Consensus Statement Supporting High-Frequency (10 kHz) Spinal Cord Stimulation Therapy for Refractory Painful Diabetic NeuropathyNYSE:NVRONevro Corp
29/01/202418:30PR Newswire (US)Nevro to Report Fourth-Quarter and Full-Year 2023 Financial Results and Host Conference Call on February 21, 2024NYSE:NVRONevro Corp
18/01/202418:15PR Newswire (US)Nevro Announces Positive Coverage Update from Carelon Healthcare for the Treatment of Painful Diabetic NeuropathyNYSE:NVRONevro Corp
17/01/202418:15PR Newswire (US)Nevro to Highlight 25 Scientific Abstracts at 2024 North American Neuromodulation Society (NANS) Annual MeetingNYSE:NVRONevro Corp
 Apresentando as notícias mais relevantes sobre:NYSE:NVRO

Seu Histórico Recente

BOV
PRIO3
PETRORIO ON
BOV
IBOV
Índice Bovespa
BOV
PCAR3
PÃO DE AÇUCAR ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados